<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/9B520E8D-05F2-4A18-9EDF-C1503366E9E1"><gtr:id>9B520E8D-05F2-4A18-9EDF-C1503366E9E1</gtr:id><gtr:name>Eli Lilly &amp; Company Ltd</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/7801F008-7C77-45E7-90E9-4345B47D138E"><gtr:id>7801F008-7C77-45E7-90E9-4345B47D138E</gtr:id><gtr:name>University of Plymouth</gtr:name><gtr:address><gtr:line1>Drake Circus</gtr:line1><gtr:line4>Plymouth</gtr:line4><gtr:line5>Devon</gtr:line5><gtr:postCode>PL4 8AA</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/5BFB9036-9D16-4AB9-A9EF-097BB6FBD69A"><gtr:id>5BFB9036-9D16-4AB9-A9EF-097BB6FBD69A</gtr:id><gtr:name>Aston University</gtr:name><gtr:department>Sch of Life and Health Sciences</gtr:department><gtr:address><gtr:line1>Aston Triangle</gtr:line1><gtr:line4>Birmingham</gtr:line4><gtr:postCode>B4 7ET</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/5BFB9036-9D16-4AB9-A9EF-097BB6FBD69A"><gtr:id>5BFB9036-9D16-4AB9-A9EF-097BB6FBD69A</gtr:id><gtr:name>Aston University</gtr:name><gtr:address><gtr:line1>Aston Triangle</gtr:line1><gtr:line4>Birmingham</gtr:line4><gtr:postCode>B4 7ET</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/9B520E8D-05F2-4A18-9EDF-C1503366E9E1"><gtr:id>9B520E8D-05F2-4A18-9EDF-C1503366E9E1</gtr:id><gtr:name>Eli Lilly &amp; Company Ltd</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/7801F008-7C77-45E7-90E9-4345B47D138E"><gtr:id>7801F008-7C77-45E7-90E9-4345B47D138E</gtr:id><gtr:name>University of Plymouth</gtr:name><gtr:address><gtr:line1>Drake Circus</gtr:line1><gtr:line4>Plymouth</gtr:line4><gtr:line5>Devon</gtr:line5><gtr:postCode>PL4 8AA</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/B954D079-3E14-4665-ACA3-4BE42B3F9886"><gtr:id>B954D079-3E14-4665-ACA3-4BE42B3F9886</gtr:id><gtr:firstName>Ian</gtr:firstName><gtr:otherNames>Martin</gtr:otherNames><gtr:surname>Stanford</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0300179"><gtr:id>6D352A73-FA3E-4FD1-BF90-1D4912E1194B</gtr:id><gtr:title>Cellular and subcellular location, density and efficacy of striato-pallidal and pallido-pallidal gabaergic synapses.</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0300179</gtr:grantReference><gtr:abstractText>The globus pallidus (GP) is a component of the basal ganglia (BG), which plays a crucial role in the control of voluntary movement. Indeed pathology of the BG can lead to Parkinson?s disease and dyskinesias. Neurones of the GP receive excitatory input from the subthalamic nucleus (STN) and inhibitory input arising from the striatum and other GP cells. These two inhibitory inputs not only contact different regions of each GP cell but preliminary studies indicate additional functional differences. We propose to identify and characterize, at the level of single cells, these two classes of inhibitory input on the basis of electrical (biophysical) properties and specific molecular markers. 

Recordings will be made from single and connected pairs of GP neurones in brain slice preparations. GABA synapses, the specialized structures formed between brain cells that permit cell-cell inhibitory communication, will then be studied. Functional, physiological data and its capacity for modulation will be linked with the number, type and precise location of the synapses which give rise to the physiological data. These studies will give an unprecedented insight into the inhibitory circuitry of the GP, highlighting functional differences in the connectivity that may provide differential targets for novel therapeutic approaches to extra-pyramidal motor disorders.</gtr:abstractText><gtr:technicalSummary>As a central integrator of basal ganglia (BG) function, the external segment of the globus pallidus (GP) plays a critical role in the control of voluntary movement. Driven by intrinsic mechanisms and excitatory glutamatergic input from the subthalamic nucleus (STN), GP neurones receive GABAergic inhibitory input from the striatum and from local axon collaterals of neighbouring pallidal neurones. Electrophysiological and morphological data provide evidence of functional differences between these two inhibitory inputs suggesting that they subserve different functions. These functional differences will be explored in studies of short-term plasticity, quantal physiology and neuroanatomical techniques detailing postsynaptic receptor location, density and receptor subunit composition, which define their functional characteristics. 

Whole-cell electrophysiological recordings will be made from single and pairs of synaptically coupled GP neurones in an in vitro preparation, which maintains functional connectivity. Basic synaptic physiology and quantal properties of transmitter release from striatal and pallidal inputs will then be determined by the method of mean variance analysis. The dynamic modulation of inhibitory synaptic transmission in the GP will also be studied using paired pulse and train stimulation. These electrophysiological data will be combined with histochemical and immunocytochemical analysis of pre- and post-synaptic elements to give unprecedented insights into the inhibitory circuitry of the GP, highlighting functional differences in the synaptic physiology which will impact on our understanding of BG function and provide differential targets for novel therapeutic interventions in extra-pyramidal motor disorders.</gtr:technicalSummary><gtr:fund><gtr:end>2010-04-30</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2004-05-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>576590</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Eli Lilly &amp; Company Ltd</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Neuronal oscillations in the cortical-BG circuit</gtr:description><gtr:id>30437AEA-C59D-440D-A16B-466F3C334637</gtr:id><gtr:impact>none as yet</gtr:impact><gtr:partnerContribution>BBSRC 4yr CASE studentship</gtr:partnerContribution><gtr:piContribution>Main supervisor 
BBSRC 4yr CASE studentship</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Plymouth</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Dr Stephen D. Hall</gtr:description><gtr:id>A162261C-7260-4572-95B0-D1BCD57259E9</gtr:id><gtr:impact>Hall S.D., Yamawaki N., Clauss R., Fisher A., Woodhall G.L., Stanford I.M. (2009) GABA(A) a1-subunit mediated desynchronization of elevated low frequency oscillations alleviates specific dysfunction in stroke - a case report. Clin. Neurophys. (in press) Hall S.D., Woodhall G.L., Furlong P.L., Williams A, Stanford I.M. (2009) Zolpidem desynchronization of pathological beta oscillatory activity in motor cortex in Parkinson's disease. Soc. Neurosci.</gtr:impact><gtr:partnerContribution>As an expert in MEG patient recordings.</gtr:partnerContribution><gtr:piContribution>To provide training in brain slice preparation and recording techniques. Intergration of MEG results with in vitro data.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Anatomical Neuropharmacology Unit</gtr:department><gtr:description>Dr Peter J. Magill</gtr:description><gtr:id>FB151664-0C54-4C31-AE42-F865CCB8DF89</gtr:id><gtr:impact>Yamawaki N., Sims R.E., Magill P.J. Stanford I.M. (2009) Synaptic plasticity mediated by high and low frequency stimulation at cortico-subthalamic synapses Soc. Neurosci.</gtr:impact><gtr:partnerContribution>Overseeing procurement of equipment and transfer of expertise in production of 6-hydroxydopamine-lesioned animals and in vivo electrophysiological recording techniques.</gtr:partnerContribution><gtr:piContribution>In vitro whole cell recordings from neurons of the subthalamic nucleus.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>School visits</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>1621B5D5-49A9-4A41-A076-B1D7454D2717</gtr:id><gtr:impact>30 pupils attended

School asked for dollow up visits at Aston University</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2011,2012,2013</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>125000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>RCUK Fellowship</gtr:description><gtr:end>2011-09-02</gtr:end><gtr:fundingOrg>Research Councils UK (RCUK)</gtr:fundingOrg><gtr:id>036168E2-0A39-4261-91DC-B79A648D657A</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2006-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>121000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC CASE studentship</gtr:description><gtr:end>2016-09-02</gtr:end><gtr:fundingOrg>Eli Lilly &amp; Company Ltd</gtr:fundingOrg><gtr:id>0BB79285-DE0B-4E67-A83D-8CC42CC0F080</gtr:id><gtr:sector>Private</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>177000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant/Parkinson's UK</gtr:description><gtr:end>2014-09-02</gtr:end><gtr:fundingOrg>Parkinson's UK (Parkinson's Disease Society)</gtr:fundingOrg><gtr:id>395CBC65-DAA1-4AB4-A627-DEF67A5700A8</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>61000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>ReGen Therapeutics Plc. Project Funding</gtr:description><gtr:end>2008-09-02</gtr:end><gtr:fundingOrg>Regen Therapeutics Ltd</gtr:fundingOrg><gtr:id>4A78F244-E776-41C2-90C5-6B72F3453729</gtr:id><gtr:sector>Private</gtr:sector><gtr:start>2007-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>203000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project grant/ Parkinson's UK</gtr:description><gtr:end>2011-09-02</gtr:end><gtr:fundingOrg>Parkinson's UK (Parkinson's Disease Society)</gtr:fundingOrg><gtr:id>54408B94-FF80-4D3A-8772-B08E98FB948E</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>For the use of low, sub-sedative doses of the hypnotic drug zolpidem as a cognitive enhancer in patients with brain injury (and neurodegenerative disease) through the de-synchronisation of pathological low frequency neuronal oscillatory activity. Inventors Stanford, Woodhall, Hall -Aston University</gtr:description><gtr:id>C3E0A724-D631-4E0C-9B77-4D36215FB4E2</gtr:id><gtr:impact>NA</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:patentId>WO2009144483</gtr:patentId><gtr:protection>Patent granted</gtr:protection><gtr:title>The Use of Zolipidem for Cognitive Enhancement</gtr:title><gtr:yearProtectionGranted>2009</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/799C1F88-D449-4969-A53B-A91B869AA88F"><gtr:id>799C1F88-D449-4969-A53B-A91B869AA88F</gtr:id><gtr:title>Subthalamic nucleus neurones in slices from 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mice show irregular, dopamine-reversible firing pattern changes, but without synchronous activity.</gtr:title><gtr:parentPublicationTitle>Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b27d36db19d0e467a6921245842cd030"><gtr:id>b27d36db19d0e467a6921245842cd030</gtr:id><gtr:otherNames>Wilson CL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0306-4522</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F9BCC961-8B67-416B-92FE-319D105FA134"><gtr:id>F9BCC961-8B67-416B-92FE-319D105FA134</gtr:id><gtr:title>Differential localization of GABA(A) receptor subunits in relation to rat striatopallidal and pallidopallidal synapses.</gtr:title><gtr:parentPublicationTitle>The European journal of neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/cc6e59c0d85d126ecdcad679624dce9a"><gtr:id>cc6e59c0d85d126ecdcad679624dce9a</gtr:id><gtr:otherNames>Gross A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0953-816X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/09607EDC-2E9C-4D8D-A379-CC6CCDDDD721"><gtr:id>09607EDC-2E9C-4D8D-A379-CC6CCDDDD721</gtr:id><gtr:title>Functional characterization of GABAergic pallidopallidal and striatopallidal synapses in the rat globus pallidus in vitro.</gtr:title><gtr:parentPublicationTitle>The European journal of neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/59e611a8a2be3358076fa69598a96e46"><gtr:id>59e611a8a2be3358076fa69598a96e46</gtr:id><gtr:otherNames>Sims RE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0953-816X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/451BEEB5-B793-4C14-AEAA-4CC2E6C312B9"><gtr:id>451BEEB5-B793-4C14-AEAA-4CC2E6C312B9</gtr:id><gtr:title>Depolarisation and suppression of burst firing activity in the mouse subthalamic nucleus by dopamine D1/D5 receptor activation of a cyclic-nucleotide gated non-specific cation conductance.</gtr:title><gtr:parentPublicationTitle>Neuropharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d5575eee13bfc21bcd53a29e1829e8a7"><gtr:id>d5575eee13bfc21bcd53a29e1829e8a7</gtr:id><gtr:otherNames>Loucif AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0028-3908</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F1A38B8C-7659-4123-9A0D-EE74A8FEF815"><gtr:id>F1A38B8C-7659-4123-9A0D-EE74A8FEF815</gtr:id><gtr:title>Functional presynaptic HCN channels in the rat globus pallidus.</gtr:title><gtr:parentPublicationTitle>The European journal of neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2b86681fd158601db5b7abf12fe528be"><gtr:id>2b86681fd158601db5b7abf12fe528be</gtr:id><gtr:otherNames>Boyes J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0953-816X</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0300179</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>